fda semaglutide shortage resolved 2025 announcement ISPOR 2025: Exploring reasons for GLP-1 discontinuation FDA declares end to Wegovy

hesitation increases discomfort

But the drug had failed to slow cognitive decline in a clinical trial, and more than a third of people in the trial who received it had shown evidence of brain swelling that concerned doctors

The first GLP-1 drug, exenatide, was approved back in 2005 when I was in pharmacy school

Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies

Additionally, FDA does not consider convenience in administering a particular compounded drug product (e.g., a ready-to-use form) or the cost of the compounded drug product as compared with an FDA-approved drug product when assessing clinical need. The notice also states that the FDA carefully reviewed the nominations it received and it did not identify sufficient evidence to include semaglutide, tirzepatide, and liraglutide on the 503B Bulks List

A monthly supply of the drug can cost over $1,300, according to information from SingleCare